Data Bridge Market Research analyses that the prostate cancer nuclear medicine diagnostics market which was USD 389.14 million in 2021, is expected to reach USD 1024.35 million by 2029, at a CAGR of 11.7% during the forecast period 2022 to 2029
Nuclear medicines are widely used in radiopharmaceutical applications which are used in cancer treatment and bone metastases. When they compared to X-rays and other external radiographic imaging devices, it is not only useful for doctors' diagnosis but also a convenient and safe alternative for patients. Nuclear medicine used in diagnostic procedures includes F-18, Tc-99, Ga-67, and I-123, while treatment procedures include I-131, Ir-192, Y-90, I-125, and Lu-177.
Data Bridge Market Research analyses that the prostate cancer nuclear medicine diagnostics market which was USD 389.14 million in 2021, is expected to reach USD 1024.35 million by 2029, at a CAGR of 11.7% during the forecast period 2022 to 2029.
Download a Sample PDF Copy of this Report to understand the structure of the complete report (Including Full TOC, Table & Figures) https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-prostate-cancer-nuclear-medicine-diagnostics-market
Market Overview
Prostate cancer affects the prostate glands in men. Prostate cancer is the second most common cancer in men after skin cancer. Family history, advanced age, and race are all common risk factors for prostate cancer. Nuclear medicine is imaging that requires radioactive materials. It is an effective method for detecting and treating prostate cancer and it assists radiologists in determining the stage of the disease. Prostate cancer nuclear medicine diagnostics is a useful method to detect and treat prostate cancer and helps radiologists to figure out the stage of cancer.
Some of the major players operating in the prostate cancer nuclear medicine diagnostics market are:
-
Lantheus (U.S.)
-
Theragnostics Ltd (U.K.)
-
Jubilant Pharma Limited (U.S.)
-
NCM-USA LLC (U.S.)
-
Telix Pharmaceuticals Ltd (Australia)
-
Cardinal Health (U.S.)
-
General Electric (U.S.)
-
Lantheus (U.S.)
-
Bayer AG (Germany)
-
Bracco Diagnostic Inc. (Italy)
-
NorthStar Medical Radioisotopes, LLC (U.S.)
-
Eckert & Ziegler. (Germany)
-
Jubilant DraxImage, Inc. (Canada)
-
PharmaLogic Holdings Corp. (U.S.)
-
Institute of Isotopes Co., Ltd (Hungary)
-
SHINE Medical Technologies, LLC (U.S.)
-
Global Medical Solutions LLC (China)Global Prostate Cancer Nuclear Medicine Diagnostics Market ScopeThe Global prostate cancer nuclear medicine diagnostics market is segmented on the basis of product, type, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market.Type
-
Single Photon Emission Computed Tomography (SPECT)
-
Photon Emission Computed Tomography (PET)ProductF-18
-
C11
-
GA 68 PSMAApplication
-
Hospitals
-
Clinics
-
OthersBrowse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-respiratory-disposables-marketTable of Content:
Chapter 1: Market overview
Chapter 3: Regional analysis of the Middle East and Africa Infection Control market industry
Chapter 4: Regional Analysis of the Middle East and Africa Infection Control Market on Types and applications
Chapter 5: Revenue analysis based on types and Applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-prostate-cancer-nuclear-medicine-diagnostics-market
Browse Trending Reports:
About Data Bridge Market Research:
An absolute way to predict the future is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing adequate information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: – [email protected]
Comments
0 comment